A Contract Development and Manufacturing Organization handles drug development and production for other pharma or biotech companies. The work spans process development, scale-up, GMP manufacturing, fill-finish, packaging, and analytical testing.

Which European countries have the most CDMO capacity?

Switzerland and Germany lead by depth and quality (Basel, Heidelberg, Mainz). Poland adds large-scale manufacturing capacity, Lithuania has a growing biologics CDMO presence anchored in Vilnius, and the Nordics carry strong fill-finish and aseptic operators in Denmark and Sweden.

How are these CDMO companies verified?

Every profile is hand-reviewed against an audit framework: leadership identity confirmed by primary source, physical site address sourced from official disclosures, regulatory matrix (GMP / ISO-13485 / GLP / FDA-Inspected) backed by certification documents, and a registry note explaining the company's current operating context.

Can I compare two CDMO providers side by side?

Yes — use the Compare button on any company card to add it to a comparison set (up to 3 companies), then open the /compare page for a side-by-side view of leadership, certifications, and operating scale.

Category and country

CDMO companies in Switzerland

6 cdmo profiles in Switzerland. Every profile is hand-reviewed with leadership, certifications, and public sources.

All Switzerland biotech CDMO across Europe

Profiles6

Verified6

With certifications6

Cities6

Category view

Where does cdmo cluster in Switzerland?

Barbengo (1), Basel (1), Bubendorf (1), and Geneva (1) Most visible profiles: Cerbios-Pharma SA, KBI Biopharma SA (Geneva), Celonic, and CARBOGEN AMCIS.

Category view

Which standards are already visible?

GMP (6) Latest review: 24 April 2026. Review cycle: April 2026.

Full list

CDMO profiles in Switzerland

6 profiles match the active filter.

Barbengo-Lugano privately held pharmaceutical CDMO with more than forty years of industry experience, specializing in high-potency active pharmaceutical ingredients, antibody-drug conjugates, and recombinant proteins for third-party pharma partners.

Lead: Emanuela MalacridaChief Executive Officer
Scale: Commercial pharmaceutical CDMO manufacturing

Geneva 94,000-square-foot integrated biologics CDMO combining Selexis cell line development and KBI mammalian contract manufacturing at a single site operating within JSR Life Sciences.

Lead: Ulrich ValleySenior Vice President, Operations and Site Head, Geneva
Scale: Integrated biologics CDMO manufacturing

Basel biopharmaceutical CDMO with Swiss GMP operations spanning cell-line development, process development, and biologics manufacturing.

Lead: Samanta CimitanChief Executive Officer
Scale: Commercial and development-stage biologics platform

Swiss CDMO with major operations in Bubendorf, providing drug-substance development, drug-product services, and commercial manufacturing for small molecules and biologics.

Lead: Stephan FritschiChief Executive Officer
Scale: Commercial and development-stage CDMO platform

Zofingen-led Swiss CDMO and API network operating a large regulated manufacturing footprint across drug substances and finished dosage.

Lead: Marcel ImwinkelriedChief Executive Officer
Scale: Global CDMO manufacturing

Swiss commercial biologics and advanced-manufacturing titan spanning mammalian, microbial, and drug-product supply for global biopharma clients.

Lead: Renzo CicilliniSite Head Visp
Scale: Global commercial CDMO

Related brief

Read deeper on this category

Market brief

European CDMO Capacity 2026: Biologics, Fill-Finish, Small Molecule

Where to look for biologics, fill-finish, small-molecule, and specialised CDMO capacity across Europe in 2026 — 33 CDMOs in the directory across 9 countries, organised by what they actually do and where they sit.

Open brief

FAQ

Frequently asked questions on this category

What is a CDMO?: A Contract Development and Manufacturing Organization handles drug development and production for other pharma or biotech companies. The work spans process development, scale-up, GMP manufacturing, fill-finish, packaging, and analytical testing.
Which European countries have the most CDMO capacity?: Switzerland and Germany lead by depth and quality (Basel, Heidelberg, Mainz). Poland adds large-scale manufacturing capacity, Lithuania has a growing biologics CDMO presence anchored in Vilnius, and the Nordics carry strong fill-finish and aseptic operators in Denmark and Sweden.
How are these CDMO companies verified?: Every profile is hand-reviewed against an audit framework: leadership identity confirmed by primary source, physical site address sourced from official disclosures, regulatory matrix (GMP / ISO-13485 / GLP / FDA-Inspected) backed by certification documents, and a registry note explaining the company's current operating context.
Can I compare two CDMO providers side by side?: Yes — use the Compare button on any company card to add it to a comparison set (up to 3 companies), then open the /compare page for a side-by-side view of leadership, certifications, and operating scale.

Next step

Compare companies or open the wider market.

Use the compare tool to view two or three companies side by side, or open the country hub for the full market view.

Open compare Suggest a company

CDMO companies in Switzerland

Where does cdmo cluster in Switzerland?

Which standards are already visible?

CDMO profiles in Switzerland

Cerbios-Pharma SA

KBI Biopharma SA (Geneva)

Celonic

CARBOGEN AMCIS

Siegfried

Lonza

Read deeper on this category

European CDMO Capacity 2026: Biologics, Fill-Finish, Small Molecule

Frequently asked questions on this category

Compare companies or open the wider market.